Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.

Genet Med 2017 05 22;19(5):537-545. Epub 2016 Sep 22.

Harvard Medical School, Boston, Massachusetts, USA.

Purpose: To measure the frequency of prescription medication changes following direct-to-consumer personal genomic testing (DTC-PGT) and their association with the pharmacogenomic results received.

Methods: New DTC-PGT customers were enrolled in 2012 and completed surveys prior to the return of results and 6 months after results; DTC-PGT results were linked to survey data. "Atypical response" pharmacogenomic results were defined as those indicating an increase or decrease in risk of an adverse drug event or likelihood of therapeutic benefit. At follow-up, participants reported prescription medication changes and health-care provider consultation.

Results: Follow-up data were available from 961 participants, of whom 54 (5.6%) reported changing a medication they were taking or starting a new medication due to their DTC-PGT results. Of these, 45 (83.3%) reported consulting with a health-care provider regarding the change. Pharmacogenomic results were available for 961 participants, of which 875 (91.2%) received one or more atypical response results. For each such result received, the odds of reporting a prescription medication change increased 1.57 times (95% confidence interval = 1.17, 2.11).

Conclusion: Receipt of pharmacogenomic results indicating an atypical drug response is common with DTC-PGT and is associated with prescription medication changes; however, fewer than 1% of consumers report unsupervised changes at 6 months after testing.Genet Med advance online publication 22 September 2016.

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2016.141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362351PMC
May 2017
31 Reads

Publication Analysis

Top Keywords

prescription medication
20
medication changes
16
961 participants
8
personal genomic
8
direct-to-consumer personal
8
health-care provider
8
genomic testing
8
changes direct-to-consumer
8
medication
6
prescription
5
dtc-pgt
5
changes
5
received odds
4
drug event
4
odds reporting
4
reporting prescription
4
adverse drug
4
event likelihood
4
result received
4
atypical response
4

References

(Supplied by CrossRef)

AL McGuire et al.
JAMA 2008

RJ Reid et al.
Genet Med 2012

CS Bloss et al.
N Engl J Med 2011

TA Caulfield et al.
Health Law Rev 2001

DJ Kaufman et al.
J Genet Couns 2012

DA Carere et al.
Genome Med 2014

CS Bloss et al.
J Med Genet 2014

Similar Publications